{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:35:22Z","timestamp":1792002922474,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.idnow.2024.104891","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T22:59:03Z","timestamp":1711407543000},"page":"104891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of antimicrobial use and healthcare-associated infections in the UAE: Results from the first nationwide point-prevalence survey"],"prefix":"10.1016","volume":"54","author":[{"given":"Najiba","family":"Abdulrazzaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-2583","authenticated-orcid":false,"given":"Ayman","family":"Chkhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idnow.2024.104891_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/20477724.2019.1632070","article-title":"Point prevalence surveys of health-care-associated infections: a systematic review","volume":"113","author":"Saleem","year":"2019","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.idnow.2024.104891_b0010","unstructured":"Jarvis WR, Bennett & Brachman's hospital infections, sixth ed. Bennett and Brachman's hospital infections. Philadelphia, PA: Lippincott Williams & Wilkins; 2014."},{"key":"10.1016\/j.idnow.2024.104891_b0015","unstructured":"World Health Organization, GLASS report: early implementation 2017-2018. https:\/\/www.who.int\/publications\/i\/item\/9789241515061 [accessed 7 December 2022]."},{"issue":"12","key":"10.1016\/j.idnow.2024.104891_b0020","first-page":"1639","article-title":"Measuring appropriate antimicrobial use: attempts at opening the black box","volume":"63","author":"Spivak","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2024.104891_b0025","unstructured":"World Health Organization, The WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals, https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2018.01 [accessed 15 December 2022]."},{"issue":"2","key":"10.1016\/j.idnow.2024.104891_b0030","first-page":"8","article-title":"Web-based and smart mobile app for data collection: kobo toolbox\/kobo collect","volume":"57","author":"Lakshminarasimhappa","year":"2022","journal-title":"J Ind Library Assoc"},{"issue":"7","key":"10.1016\/j.idnow.2024.104891_b0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","article-title":"Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis","volume":"16","author":"Schuts","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"3","key":"10.1016\/j.idnow.2024.104891_b0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/antibiotics3030450","article-title":"A point prevalence survey of antibiotic use in 18 hospitals in Egypt","volume":"3","author":"Talaat","year":"2014","journal-title":"Antibiotics (Basel)."},{"issue":"1","key":"10.1016\/j.idnow.2024.104891_b0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jiph.2018.09.003","article-title":"Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016","volume":"12","author":"Al Matar","year":"2019","journal-title":"J Infect Public Health."},{"issue":"6","key":"10.1016\/j.idnow.2024.104891_b0050","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health."},{"issue":"10","key":"10.1016\/j.idnow.2024.104891_b0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/antibiotics10101167","article-title":"Antibiotic prevalence study and factors influencing prescription of WHO watch category antibiotic ceftriaxone in a tertiary care private not for profit hospital in Uganda","volume":"10","author":"Kizito","year":"2021","journal-title":"Antibiotics (Basel)."},{"issue":"6","key":"10.1016\/j.idnow.2024.104891_b0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/1742-6723.12326","article-title":"Factors influencing ceftriaxone use in community-acquired pneumonia: emergency doctors' perspectives","volume":"26","author":"Almatar","year":"2014","journal-title":"Emerg Med Australas."},{"issue":"11","key":"10.1016\/j.idnow.2024.104891_b0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00019053-200119110-00006","article-title":"Piperacillin\/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections","volume":"19","author":"Young","year":"2001","journal-title":"Pharmacoeconomics."},{"issue":"5","key":"10.1016\/j.idnow.2024.104891_b0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000087452","article-title":"Current guidelines for the treatment of severe pneumonia and sepsis","volume":"51","author":"Bodmann","year":"2005","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1016\/j.idnow.2024.104891_b0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med."},{"key":"10.1016\/j.idnow.2024.104891_b0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/IDR.S27965","article-title":"Evaluation of the use of piperacillin\/tazobactam (Tazocin) at Hamad General Hospital, Qatar: are there unjustified prescriptions?","volume":"5","author":"Khan","year":"2012","journal-title":"Infect Drug Resist."},{"issue":"2","key":"10.1016\/j.idnow.2024.104891_b0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/jpbs.JPBS_478_20","article-title":"Prescription pattern of empirical antibiotic therapy in the burn unit of a tertiary care setting in the Kingdom of Saudi Arabia","volume":"13","author":"Moinuddin","year":"2021","journal-title":"J Pharm Bioallied Sci."},{"key":"10.1016\/j.idnow.2024.104891_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13756-019-0609-0","article-title":"Appropriateness of antimicrobial use among septic patients managed by the critical care response team: an opportunity for improvement through de-escalation","volume":"8","author":"Al-Qahtani","year":"2019","journal-title":"Antimicrob Resist Infect Control."},{"issue":"4","key":"10.1016\/j.idnow.2024.104891_b0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/antibiotics10040366","article-title":"Exploring physicians' views, perceptions and experiences about broad-spectrum antimicrobial prescribing in a Tertiary Care Hospital Riyadh, Saudi Arabia: a qualitative approach","volume":"10","author":"Alsaleh","year":"2021","journal-title":"Antibiotics (Basel)."},{"issue":"10","key":"10.1016\/j.idnow.2024.104891_b0100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S1473-3099(20)30854-9","article-title":"Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study","volume":"21","author":"Adekoya","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.idnow.2024.104891_b0105","unstructured":"Department of Health, U.A.E., Communicable Disease Bulletin. 2019. 10 (2). https:\/\/doh.gov.ae\/-\/media\/1BAE995557FE42789AC2CDDA5262E2BB.ashx [accessed 17 December 2022]."},{"issue":"6","key":"10.1016\/j.idnow.2024.104891_b0110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.idnow.2024.104891_b0115","unstructured":"Centers for Disease Control and Prevention (CDC), Influenza Antiviral Medications: Summary for Clinicians. https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm; 2022 [accessed 17 December 2022]."},{"issue":"9","key":"10.1016\/j.idnow.2024.104891_b0120","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/vaccines10091466","article-title":"Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review","volume":"10","author":"Chan","year":"2022","journal-title":"Vaccines (Basel)."},{"issue":"12","key":"10.1016\/j.idnow.2024.104891_b0125","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.vaccine.2019.02.001","article-title":"Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward","volume":"37","author":"Abubakar","year":"2019","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.idnow.2024.104891_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)."},{"key":"10.1016\/j.idnow.2024.104891_b0135","unstructured":"Ministry of Health and Prevention, U.A.E., National Amr Surveillance Report. https:\/\/mohap.gov.ae\/assets\/download\/c6e38492\/National%20AMR%20Surveillance%20Report%202022%20MOHAP.pdf.aspx; 2022 [accessed 29 December 2022]."},{"issue":"1","key":"10.1016\/j.idnow.2024.104891_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274248","article-title":"Global prevalence of nosocomial infection: a systematic review and meta-analysis","volume":"18","author":"Raoofi","year":"2023","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.idnow.2024.104891_b0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler","year":"2013","journal-title":"Surg Infect (Larchmt)."},{"issue":"11","key":"10.1016\/j.idnow.2024.104891_b0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/bmjqs-2021-014582","article-title":"Documenting the indication for antimicrobial prescribing: a scoping review","volume":"31","author":"Saini","year":"2022","journal-title":"BMJ Qual Saf."}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:31:00Z","timestamp":1717425060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666991924000460"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104891","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of antimicrobial use and healthcare-associated infections in the UAE: Results from the first nationwide point-prevalence survey","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104891"}}